Brunell PA, Ross A, Miller LH, et al. Prevention of varicella by zoster immune globulin. N Engl J Med, 1969, 280(22):1191-1194.
[8]
Marin M, Güris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 2007, 56(RR-4):1-40.
Wasmuth EH, Miller WJ. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol, 1990, 32(3):189-193.
[20]
EMEA blood products working group. CPMP/BPWG/3726/02 Core SPC for human Varicella immunoglobulin for intramuscular use. London: 2005. http://www.ema.europa.eu/docs/en_GB/document_library/ Scientific_guideline/2009/09/WC500003432.pdf.
[3]
Feldhoff CM, Balfour HH Jr, Simmons RL, et al. Varicella in children with renal transplants. J Pediatr, 1981, 98(1):25-31.
[4]
Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics, 1987, 80(4):465-472.
[5]
Enders G, Miller E, Cradock-Watson J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet, 1994, 343(8192):1548-1551.
[11]
Forghani B, Dupuis KW, Schmidt NJ. Epitopes functional in neutralization of varicella-zoster virus. J Clin Microbiol, 1990, 28(11): 2500-2506.
J Virol, 1984, 52(1):293-297.
[13]
Grose C, Litwin V. Immunology of the varicella-zoster virus glycoproteins. J Infect Dis, 1988, 157(5):877-881.
[16]
Krah DL. Assays for antibodies to varicella-zoster virus. Infect Di Clin N Am, 1996, 10(3):507-527.
[17]
Larussa P, Steinberg S, Waithe E, et al. Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to- membrane-antigen test. J Clin Microbiol, 1987, 25(11):2059-2062.
[18]
Hammond O, Wang Y, Green T, et al. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection. J Med Virol, 2006, 78(12):1679-1687.